Basic Page | Knowledge Base

Base Technical Content in text and simple images.

Shorter Injectable-containing MDR/RR-TB Regimen: Pre-treatment evaluation and follow-up

H5Content

Pre-treatment Evaluation [PTE] of DR-TB Patients

H5Content

Key Messages for TB Counselling

H5Content

Components of Drug Resistant TB Counselling Tool

H5Content

Delamanid [Dlm] Drug Dosages and Duration

H5Content

Eligibility Criteria for the Use of Delamanid [Dlm] in MDR/RR-TB Treatment

H5Content

Bedaquiline Drug Dosages and Duration

H5Content

Eligibility Criteria for the Use of Bedaquiline [Bdq] in MDR/RR-TB Treatment

H5Content

Drugs Not Included in Groups A - C and Rationale for Non-inclusion

H5Content

Rationale for Grouping of Anti-TB Drugs

H5Content

Subscribe to Basic Page